HS
MRNA icon

Horan Securities’s Moderna MRNA Stock Holding History

Horan Securities’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-35
Closed -$4.31K – 443
2023
Q2 		$4.31K Hold
35
– – ﹤0.01% 490
2023
Q1 		$5.44K Sell
35
-86
-71% -$14.2K ﹤0.01% 460
2022
Q4 		$21.8K Sell
121
-3
-2% -$491 0.01% 288
2022
Q3 		$15K Hold
124
– – 0.01% 307
2022
Q2 		$20K Sell
124
-203
-62% -$29K 0.01% 258
2022
Q1 		$56K Sell
327
-139
-30% -$23.4K 0.03% 167
2021
Q4 		$118K Buy
+466
New +$136K 0.07% 121
2021
Q2 		$179K Sell
761
-435
-36% -$77.7K 0.13% 76
2021
Q1 		$157K Buy
1,196
+16
+1% +$2.32K 0.13% 60
2020
Q4 		$123K Buy
+1,180
New +$119K 0.1% 69

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Horan Securities's MRNA Position: Q3 2023 in Review

Horan Securities sold out of Moderna (MRNA) in Q3 2023, closing a stake of 35 shares — an estimated $4.31K sold.

Horan Securities first reported a position in MRNA in Q4 2020 and held it in 10 quarters. The position peaked at $179K in Q2 2021. 888 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Horan Securities reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Horan Securities sold 35 Moderna shares in Q3 2023, an estimated $4.31K.
  • Horan Securities first reported a position in Moderna in Q4 2020 and held it in 10 quarters.
  • Horan Securities's Moderna position peaked at $179K in Q2 2021.
  • 888 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Horan Securities's 13F filing for Q3 2023, filed 1 Nov 2023.